Nirmatrelvir and ritonavir. Information for patients

Abstract

The Pan American Health Organization presents this brochure in order to inform patients and the general public about the combination of nirmatrelvir with ritonavir. This treatment, which requires a prescription, is indicated for mild to moderate cases in people with a positive confirmatory test who are at high risk of progression to severe or critical illness and hospitalization.